Table 2.

Survival analysis by CRS for each scored tissue sample site and the entire cohort.

Site	CRS	OS				PFS
		N	Events	Median	p-Value *	N	Events	Median	p-Value *
Omentum	3 tier				0.055				0.022
	1	35	25	40.5		35	33	11.7
	2	50	28	34.4		49	43	12.7
	3	16	6	59.9		15	10	20.3
	2 tier				0.018				0.021
	1/2	85	53	36.0		84	76	12.2
	3	16	6	59.9		15	10	20.3
Adnexa	3 tier				0.008				0.004
	1	60	36	26.9		60	54	11.5
	2	71	31	45.2		71	57	14.0
	3	13	4	NE		12	7	22.3
	2 tier				0.042				0.035
	1/2	131	67	39.5		131	111	12.6
	3	13	4	NE		12	7	22.3
Entire cohort	3 tier				0.002				<0.001
	1	95	61	35.9		95	87	11.6
	2	121	59	39.1		120	100	14.0
	3	29	10	81.8		27	17	20.3
	2 tier				0.002				0.001
	1/2	216	120	38.0		215	187	12.4
	3	29	10	81.8		27	17	20.3

* Log–rank test. Overall survival, OS; progression-free survival, PSF; not estimable, NE.